Merck & Co., Inc.
MRK
$103.46
$0.980.96%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 59.31B | 58.31B | 57.87B | 59.28B | 58.97B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.31B | 58.31B | 57.87B | 59.28B | 58.97B |
| Cost of Revenue | 15.96B | 15.61B | 15.77B | 17.21B | 17.45B |
| Gross Profit | 43.35B | 42.70B | 42.10B | 42.08B | 41.52B |
| SG&A Expenses | 10.10B | 10.03B | 9.95B | 9.77B | 9.94B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.13B | 49.92B | 39.45B | 39.00B | 40.87B |
| Operating Income | 9.18B | 8.39B | 18.42B | 20.29B | 18.11B |
| Income Before Tax | 7.45B | 5.41B | 15.23B | 16.44B | 16.84B |
| Income Tax Expenses | 2.83B | 2.29B | 2.19B | 1.92B | 1.51B |
| Earnings from Continuing Operations | 4.62K | 3.12K | 13.05K | 14.53K | 15.33K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -62.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -13.00M | -13.00M | -15.00M | -8.00M | -11.00M |
| Net Income | 4.61B | 3.11B | 13.03B | 14.52B | 15.26B |
| EBIT | 9.18B | 8.39B | 18.42B | 20.29B | 18.11B |
| EBITDA | 12.88B | 12.05B | 22.09B | 24.08B | 21.83B |
| EPS Basic | 1.82 | 1.23 | 5.14 | 5.74 | 6.03 |
| Normalized Basic EPS | 2.23 | 2.03 | 4.48 | 4.94 | 4.36 |
| EPS Diluted | 1.80 | 1.22 | 5.12 | 5.71 | 6.01 |
| Normalized Diluted EPS | 2.22 | 2.01 | 4.46 | 4.92 | 4.34 |
| Average Basic Shares Outstanding | 10.15B | 10.15B | 10.14B | 10.13B | 10.12B |
| Average Diluted Shares Outstanding | 10.18B | 10.18B | 10.18B | 10.17B | 10.15B |
| Dividend Per Share | 2.88 | 2.84 | 2.80 | 2.76 | 2.72 |
| Payout Ratio | 159.35% | 232.56% | 54.64% | 48.30% | 45.25% |
